U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 139

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:27274843-30817038
GRCh38:
Chr17:28947825-32490020
ABHD15, ADAP2, ANKRD13B, ATAD5, BLMH, C17orf75, CDK5R1, COPRS, CORO6, CPD, CRLF3, CRYBA1, EFCAB5, EVI2A, EVI2B, GIT1, GOSR1, LOC105371730, LOC106113036, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771182, LOC108771183, LOC108771184, LOC108783647, LOC108783648, LOC108783652, LOC108783653, LOC110121426, LOC110806262, LOC111811965, LOC112529904, LOC112529905, LOC112529906, LOC112529907, LOC113939959, LOC113939960, LOC121587584, LOC121587585, LOC121587586, LOC125177445, LOC125177446, LOC125177447, LOC125177448, LOC125177449, LOC125177450, LOC125177451, LOC125177452, LOC125177453, LOC125177454, LOC125177455, LOC126862527, LOC126862528, LOC126862529, LOC126862530, LOC126862531, LOC129390847, LOC129390848, LOC129390849, LOC129390850, LOC129390851, LOC129390852, LOC130060584, LOC130060585, LOC130060586, LOC130060587, LOC130060588, LOC130060589, LOC130060590, LOC130060591, LOC130060592, LOC130060593, LOC130060594, LOC130060595, LOC130060596, LOC130060597, LOC130060598, LOC130060599, LOC130060600, LOC130060601, LOC130060602, LOC130060603, LOC130060604, LOC130060605, LOC130060606, LOC130060607, LOC130060608, LOC130060609, LOC130060610, LOC130060611, LOC130060612, LOC130060613, LOC130060614, LOC130060615, LOC130060616, LOC130060617, LOC130060618, LOC130060619, LOC130060620, LOC130060621, LOC130060622, LOC130060623, LOC130060624, LOC130060625, LOC130060626, LOC130060627, LOC130060628, LOC130060629, LOC130060630, LOC130060631, LOC130060632, LOC130060633, LOC130060634, LOC130060635, LOC130060636, LOC130060637, LOC130060638, LOC130060639, LOC130060640, LOC130060641, LOC130060642, LOC130060643, LOC130060644, LOC130060645, LOC130060646, LOC130060647, LOC130060648, LOC130060649, LOC130060650, LOC130060651, LOC130060652, LOC130060653, LOC130060654, LOC130060655, LOC130060656, LOC130060657, LOC130060658, LOC130060659, LOC130060660, LOC130060661, LOC130060662, LOC130060663, LOC130060664, LOC130060665, LOC130060666, LOC130060667, LOC130060668, LOC130060669, LOC130060670, LOC130060671, LOC130060672, LOC130060673, LOC130060674, LOC130060675, LOC130060676, LOC130060677, LOC130060678, LOC130060679, LOC130060680, LOC130060681, LOC130060682, LOC130060683, LRRC37B, MIR193A, MIR3184, MIR365B, MIR365BHG, MIR423, MIR4523, MIR4724, MIR4725, MIR4733, MIR4733HG, MIR632, MYO18A, NF1, NSRP1, NUFIP2, OMG, PHF12, PIPOX, PSMD11, RAB11FIP4, RHBDL3, RHOT1, RNF135, SEZ6, SLC6A4, SSH2, STIN2-VNTR, SUZ12, TAOK1, TBC1D29P, TEFM, TMIGD1, TP53I13, TRT-CGT4-1, UTP6, ZNF207
See casesPathogenic
(Dec 10, 2012)
no assertion criteria provided
2.
GRCh37:
Chr17:28952286-30386515
GRCh38:
Chr17:30625268-32059496
See casesPathogenic
(Aug 26, 2013)
no assertion criteria provided
3.
GRCh37:
Chr17:28957752-30415399
GRCh38:
Chr17:30630734-32088380
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr17:28993036-30412788
GRCh38:
Chr17:30666018-32085769
See casesPathogenic
(Aug 1, 2014)
no assertion criteria provided
5.
GRCh37:
Chr17:28994990-30350877
GRCh38:
Chr17:30667972-32023858
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
6.
GRCh37:
Chr17:28999834-30326958
GRCh38:
Chr17:30672816-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr17:29004621-30398720
GRCh38:
Chr17:30677603-32071701
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
8.
GRCh37:
Chr17:29005171-30400885
GRCh38:
Chr17:30678153-32073866
See casesPathogenic
(Mar 11, 2013)
no assertion criteria provided
9.
GRCh37:
Chr17:29011937-30348421
GRCh38:
Chr17:30684919-32021402
See casesPathogenic
(Apr 30, 2011)
no assertion criteria provided
10.
GRCh37:
Chr17:29033863-30326952
GRCh38:
Chr17:30706845-31999933
See casesPathogenic
(Sep 21, 2012)
no assertion criteria provided
11.
GRCh37:
Chr17:29033881-30321643
GRCh38:
Chr17:30706863-31994624
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
12.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
13.
GRCh37:
Chr17:29033882-30426780
GRCh38:
Chr17:30706864-32099761
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
14.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
15.
GRCh37:
Chr17:29094212-30264505
GRCh38:
Chr17:30767194-31937486
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
16.
GRCh37:
Chr17:29768369-30332225
GRCh38:
Chr17:31441351-32005206
See casesUncertain significance
(Aug 26, 2011)
no assertion criteria provided
17.
GRCh37:
Chr17:30264281
GRCh38:
Chr17:31937262
SUZ12H6Dnot providedUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr17:30264283
GRCh38:
Chr17:31937264
SUZ12H6Qnot providedUncertain significance
(Feb 15, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr17:30264354
GRCh38:
Chr17:31937335
SUZ12A30VInborn genetic diseasesUncertain significance
(Mar 6, 2023)
criteria provided, single submitter
20.
GRCh37:
Chr17:30264366
GRCh38:
Chr17:31937347
SUZ12A34GInborn genetic diseasesLikely benign
(May 10, 2023)
criteria provided, single submitter
21.
GRCh37:
Chr17:30264375
GRCh38:
Chr17:31937356
SUZ12S37LInborn genetic diseasesUncertain significance
(May 5, 2023)
criteria provided, single submitter
22.
GRCh37:
Chr17:30264398
GRCh38:
Chr17:31937379
SUZ12S45GInborn genetic diseasesLikely benign
(Apr 7, 2023)
criteria provided, single submitter
23.
GRCh37:
Chr17:30264405
GRCh38:
Chr17:31937386
SUZ12G47AInborn genetic diseasesUncertain significance
(Jul 16, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr17:30264416
GRCh38:
Chr17:31937397
SUZ12S51GInborn genetic diseasesUncertain significance
(Apr 21, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr17:30264421
GRCh38:
Chr17:31937402
SUZ12Y52*not specifiedPathogenic
(Sep 22, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr17:30264426-30264428
GRCh38:
Chr17:31937407-31937409
SUZ12S59delnot providedBenign
(Jun 1, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr17:30264435
GRCh38:
Chr17:31937416
SUZ12S57FInborn genetic diseasesUncertain significance
(May 22, 2023)
criteria provided, single submitter
28.
GRCh37:
Chr17:30264457
GRCh38:
Chr17:31937438
SUZ12not providedLikely benign
(Dec 31, 2019)
criteria provided, single submitter
29.
GRCh37:
Chr17:30264476
GRCh38:
Chr17:31937457
SUZ12V71Mnot providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:30264515
GRCh38:
Chr17:31937496
SUZ12E84KInborn genetic diseasesUncertain significance
(Feb 15, 2023)
criteria provided, single submitter
31.
GRCh37:
Chr17:30264526
GRCh38:
Chr17:31937507
SUZ12not providedLikely benign
(Feb 1, 2023)
criteria provided, single submitter
32.
GRCh37:
Chr17:30264544
GRCh38:
Chr17:31937525
SUZ12Imagawa-Matsumoto syndromeUncertain significance
(Jan 8, 2020)
criteria provided, single submitter
33.
GRCh37:
Chr17:30264547
GRCh38:
Chr17:31937528
SUZ12Imagawa-Matsumoto syndrome, not providedBenign/Likely benign
(Aug 11, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr17:30264812
GRCh38:
Chr17:31937793
SUZ12not providedBenign
(Oct 1, 2023)
criteria provided, single submitter
35.
GRCh37:
Chr17:30264860
GRCh38:
Chr17:31937841
SUZ12not providedBenign
(Sep 1, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr17:30265438
GRCh38:
Chr17:31938419
SUZ12not providedBenign
(Jul 1, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr17:30266233
GRCh38:
Chr17:31939214
SUZ12not providedBenign
(Oct 1, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr17:30266462
GRCh38:
Chr17:31939443
SUZ12not providedBenign
(Oct 1, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr17:30267300
GRCh38:
Chr17:31940281
SUZ12not providedUncertain significance
(May 7, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr17:30267462-30267465
GRCh38:
Chr17:31940443-31940446
SUZ12Y117fsnot providedPathogenic
(Jul 3, 2019)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr17:30267467-30267468
GRCh38:
Chr17:31940448-31940449
SUZ12Y117fsnot providedPathogenic
(Jul 21, 2020)
criteria provided, single submitter
42.
GRCh37:
Chr17:30267480
GRCh38:
Chr17:31940461
SUZ12R121*Inborn genetic diseasesPathogenic
(Aug 19, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr17:30267506
GRCh38:
Chr17:31940487
SUZ12Imagawa-Matsumoto syndromePathogenic
(May 4, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr17:30293163
GRCh38:
Chr17:31966144
SUZ12not providedLikely benign
(Jan 1, 2023)
criteria provided, single submitter
45.
GRCh37:
Chr17:30302549
GRCh38:
Chr17:31975530
SUZ12P191A, P214Anot providedUncertain significance
(May 14, 2020)
criteria provided, single submitter
46.
GRCh37:
Chr17:30302601
GRCh38:
Chr17:31975582
SUZ12A231G, A208GInborn genetic diseasesUncertain significance
(Jun 5, 2023)
criteria provided, single submitter
47.
GRCh37:
Chr17:30302607
GRCh38:
Chr17:31975588
SUZ12S210C, S233Cnot providedUncertain significance
(Jun 11, 2023)
criteria provided, single submitter
48.
GRCh37:
Chr17:30302637
GRCh38:
Chr17:31975618
SUZ12H220R, H243RInborn genetic diseasesUncertain significance
(Oct 4, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:30302656
GRCh38:
Chr17:31975637
SUZ12not providedLikely benign
(Apr 1, 2023)
criteria provided, single submitter
50.
GRCh37:
Chr17:30302721
GRCh38:
Chr17:31975702
SUZ12N248I, N271IInborn genetic diseasesUncertain significance
(Mar 22, 2023)
criteria provided, single submitter
51.
GRCh37:
Chr17:30302721
GRCh38:
Chr17:31975702
SUZ12N271S, N248SInborn genetic diseasesUncertain significance
(Apr 13, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:30302723
GRCh38:
Chr17:31975704
SUZ12E249*, E272*Developmental disorderUncertain significance
(Aug 4, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr17:30303560-30303561
GRCh38:
Chr17:31976541-31976542
SUZ12A259fs, A282fsImagawa-Matsumoto syndromePathogenic
(Feb 21, 2020)
no assertion criteria provided
54.
GRCh37:
Chr17:30303572
GRCh38:
Chr17:31976553
SUZ12R263*, R286*SUZ12-related conditionLikely pathogenic
(Apr 10, 2023)
criteria provided, single submitter
55.
GRCh37:
Chr17:30303581
GRCh38:
Chr17:31976562
SUZ12E266K, E289KInborn genetic diseasesUncertain significance
(Aug 2, 2023)
criteria provided, single submitter
56.
GRCh37:
Chr17:30303633
GRCh38:
Chr17:31976614
SUZ12R283T, R306Tnot providedUncertain significance
(Sep 23, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr17:30310019
GRCh38:
Chr17:31983000
SUZ12R284C, R307Cnot providedUncertain significance
(Jun 1, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr17:30310102
GRCh38:
Chr17:31983083
SUZ12W311*, W334*not providedUncertain significance
(Sep 22, 2019)
criteria provided, single submitter
59.
GRCh37:
Chr17:30315353
GRCh38:
Chr17:31988334
SUZ12not providedLikely benign
(May 31, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr17:30315354
GRCh38:
Chr17:31988335
SUZ12E324K, E347Knot specifiedUncertain significance
(Aug 24, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr17:30315364
GRCh38:
Chr17:31988345
SUZ12S327F, S350FImagawa-Matsumoto syndromeLikely pathogenic
(Jun 15, 2023)
criteria provided, single submitter
62.
GRCh37:
Chr17:30315387
GRCh38:
Chr17:31988368
SUZ12T358A, T335AInborn genetic diseasesUncertain significance
(Jul 11, 2023)
criteria provided, single submitter
63.
GRCh37:
Chr17:30315413
GRCh38:
Chr17:31988394
SUZ12N343K, N366KInborn genetic diseasesUncertain significance
(Jun 28, 2023)
criteria provided, single submitter
64.
GRCh37:
Chr17:30315425
GRCh38:
Chr17:31988406
SUZ12not providedLikely benign
(May 21, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr17:30315446-30315447
GRCh38:
Chr17:31988427-31988428
SUZ12A355fs, A378fsImagawa-Matsumoto syndromeLikely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:30315461-30315462
GRCh38:
Chr17:31988442-31988443
SUZ12L362fs, L385fsAcute megakaryoblastic leukemia in down syndrome, not providedPathogenic/Likely pathogenic
(Nov 3, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:30315474
GRCh38:
Chr17:31988455
SUZ12Q364*, Q387*not providedUncertain significance
(Apr 2, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr17:30320282
GRCh38:
Chr17:31993263
SUZ12T408R, T385RInborn genetic diseases, not providedConflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr17:30320292
GRCh38:
Chr17:31993273
SUZ12Q411H, Q388Hnot providedLikely benign
(Oct 24, 2018)
criteria provided, single submitter
70.
GRCh37:
Chr17:30320293
GRCh38:
Chr17:31993274
SUZ12T389A, T412AGlobal developmental delayUncertain significance
(Nov 12, 2019)
no assertion criteria provided
71.
GRCh37:
Chr17:30320295-30320299
GRCh38:
Chr17:31993276-31993280
SUZ12E392fs, E415fsnot providedUncertain significance
(Oct 30, 2019)
criteria provided, single submitter
72.
GRCh37:
Chr17:30320325
GRCh38:
Chr17:31993306
SUZ12not providedBenign
(Dec 31, 2019)
criteria provided, single submitter
73.
GRCh37:
Chr17:30320326
GRCh38:
Chr17:31993307
SUZ12R400*, R423*Imagawa-Matsumoto syndromeLikely pathogenic
(Jan 8, 2020)
criteria provided, single submitter
74.
GRCh37:
Chr17:30320916
GRCh38:
Chr17:31993897
SUZ12not providedLikely benign
(Dec 31, 2019)
criteria provided, single submitter
75.
GRCh37:
Chr17:30320940
GRCh38:
Chr17:31993921
SUZ12C427W, C450Wnot providedUncertain significance
(Jul 18, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr17:30321000
GRCh38:
Chr17:31993981
SUZ12not providedLikely benign
(May 4, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr17:30321028-30321031
GRCh38:
Chr17:31994009-31994012
SUZ12not providedUncertain significance
(Dec 8, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr17:30321028
GRCh38:
Chr17:31994009
SUZ12Imagawa-Matsumoto syndromeLikely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr17:30321595
GRCh38:
Chr17:31994576
SUZ12G461fs, G484fsImagawa-Matsumoto syndrome, Non-immune hydrops fetalisLikely pathogenic
(Apr 16, 2020)
criteria provided, single submitter
80.
GRCh37:
Chr17:30321630
GRCh38:
Chr17:31994611
SUZ12not providedLikely benign
(Jun 4, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr17:30321706-30321707
GRCh38:
Chr17:31994687-31994688
SUZ12K498fs, K521fsnot providedPathogenic
(May 28, 2019)
criteria provided, single submitter
82.
GRCh37:
Chr17:30321730
GRCh38:
Chr17:31994711
SUZ12L506F, L529FInborn genetic diseasesUncertain significance
(May 11, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr17:30321739
GRCh38:
Chr17:31994720
SUZ12R509G, R532GSUZ12-related conditionUncertain significance
(Dec 27, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:30322591
GRCh38:
Chr17:31995572
SUZ12R512Q, R535Qnot providedUncertain significance
(Jan 22, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr17:30322644
GRCh38:
Chr17:31995625
SUZ12Q530*, Q553*Imagawa-Matsumoto syndromePathogenic
(Aug 8, 2019)
criteria provided, single submitter
86.
GRCh37:
Chr17:30322658
GRCh38:
Chr17:31995639
SUZ12Imagawa-Matsumoto syndrome, not providedBenign/Likely benign
(May 17, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr17:30322768
GRCh38:
Chr17:31995749
SUZ12T573fs, T596fsnot providedUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
88.
GRCh37:
Chr17:30322782
GRCh38:
Chr17:31995763
SUZ12not providedPathogenic
(Apr 17, 2020)
criteria provided, single submitter
89.
GRCh37:
Chr17:30322787
GRCh38:
Chr17:31995768
SUZ12Inborn genetic diseasesUncertain significance
(Sep 14, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr17:30323819
GRCh38:
Chr17:31996800
SUZ12Q599H, Q576HWeaver syndromeUncertain significance
(Feb 12, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr17:30323829
GRCh38:
Chr17:31996810
SUZ12F603L, F580LImagawa-Matsumoto syndromePathogenic
(Feb 21, 2020)
no assertion criteria provided
92.
GRCh37:
Chr17:30323846-30323847
GRCh38:
Chr17:31996827-31996828
SUZ12E587fs, E610fsnot providedPathogenic
(May 8, 2019)
criteria provided, single submitter
93.
GRCh37:
Chr17:30323851
GRCh38:
Chr17:31996832
SUZ12E610V, E587VImagawa-Matsumoto syndromePathogenic
(Feb 21, 2020)
no assertion criteria provided
94.
GRCh37:
Chr17:30323904
GRCh38:
Chr17:31996885
SUZ12Neurodevelopmental disorderUncertain significance
(May 25, 2020)
criteria provided, single submitter
95.
GRCh37:
Chr17:30325693
GRCh38:
Chr17:31998674
SUZ12Q608*, Q631*not providedPathogenic
(Sep 2, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr17:30325719
GRCh38:
Chr17:31998700
SUZ12F616L, F639Lnot providedUncertain significance
(Oct 6, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr17:30325720
GRCh38:
Chr17:31998701
SUZ12V617I, V640ITeratomaUncertain significance
(Jan 1, 2023)
no assertion criteria provided
98.
GRCh37:
Chr17:30325731
GRCh38:
Chr17:31998712
SUZ12not providedLikely benign
(Mar 29, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr17:30325740
GRCh38:
Chr17:31998721
SUZ12K623N, K646NImagawa-Matsumoto syndromeUncertain significance
(Feb 26, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr17:30325747-30325749
GRCh38:
Chr17:31998728-31998730
SUZ12K627del, K650delSUZ12-related conditionUncertain significance
(Nov 16, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination